Genta, Inc (fka GNTAQ)

[The Holder]

I'm just posting the facts as they currently stand with this company, I know you're a fact man.

Fact is, Genasense has exceeded all expectations of the EMEA and FDA with respect to the treatment of Melanoma and the treatment of CLL.

If only one application is successful, this easily hits 50 cents. Easily.

I think you can clearly see that the Agenda trial is about to provide concrete, overwhelming, confirmatory data that both the FDA and EMEA requested in order to gain approval for world-wide application.

You need to start asking yourself how much longer you're going to sit on the sideline.